Fundz

Fundz Deep Dive

Everything you need to win Rockwell Medical, Inc. — in one platform.

Who to reach, what to say, and why now on Rockwell Medical, Inc. — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Rockwell Medical, Inc. — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Rockwell Medical Enters Multi-Year Product Purchase Agreement with Leading Dialysis Provider

Dec 17, 2024•over 1 year ago

Contract Type

agreement

WixomBiotechnologyHealthcareHealth CareMedical

Description

Rockwell Medical, Inc. announced a product purchase agreement with the world's leading provider of dialysis products and services. Under the agreement, Rockwell Medical will supply the Customer with its liquid bicarbonate hemodialysis concentrates product, SteriLyte®, with expected net sales of upwards of $10 million in the first year. The agreement is set to remain in effect for three years with the option to renew for two additional one-year periods.

Company Information

Company

Rockwell Medical, Inc.

Location

30142 Wixom Road

Wixom, Michigan, United States

About

Rockwell Medical (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Rockwell Medical, Inc.'s next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.